Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm, Residual × Chemotherapy, Adjuvant × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Rectal Neoplasms 5 Lung Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Esophageal Neoplasms 3 Colonic Neoplasms 3 Central Nervous System Neoplasms 3 Breast Neoplasms, Male 3 Brain Neoplasms 3 Adenocarcinoma Of Esophagus 3 Sarcoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Osteosarcoma 2 Lymphoma 2 Head and Neck Neoplasms 2 Glioblastoma 2 Breast Carcinoma In Situ 2 Vomiting 1 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Radiation Injuries 1 Peritoneal Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Nausea 1 Medulloblastoma 1 Lymphoma, Follicular 1

Interventions

Rituximab 4 blinatumomab 3 Whole-Body Irradiation 2 Lenalidomide 2 Cyclophosphamide 2 Clofarabine 2 treosulfan 1 thymoglobulin 1 sabatolimab 1 peginterferon alfa-2a 1 obinutuzumab 1 midostaurin 1 ixazomib 1 fludarabine phosphate 1 fludarabine 1 eribulin 1 daratumumab 1 acalabrutinib 1 Trastuzumab 1 Tacrolimus 1 Sodium Chloride 1 Peripheral Blood Stem Cell Transplantation 1 Pentostatin 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Magnetic Resonance Imaging 1 Imatinib Mesylate 1 Histamine Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡